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Abstract 
Background and Review of Literature: Postoperative nausea and vomiting (PONV) is one of 
the most common patient complications following general anesthesia. Recent literature supports 
the practice of supplemental intravenous fluid administration to patients receiving general 
anesthesia with no risk of fluid volume overload.  
Purpose: The purpose of this DNP project was to assess the overall occurrence of PONV and to 
determine if patients who experienced PONV after receiving general anesthesia, were 
administered supplemental intravenous fluids during the intraoperative period.   
Methods: The project consisted of a retrospective chart review. A total of 342 electronic health 
records (EHRs) were reviewed and 57 patients were included in the DNP project.  
Implementation Plan: A project site was identified; a retrospective chart review was conducted, 
examining one month of patient EHRs who underwent general anesthesia. Data was collected 
and analyzed via Microsoft Excel, which included the amount of intravenous fluids received 
during the intraoperative period, weight, gender, surgical procedure, and ASA physical status. 
Implications/Conclusions: At the completion of the retrospective chart review, it was 
discovered that 57 (17%) out of 342 patients who underwent general anesthesia were treated for 
PONV. Of the 57 patients, 50 (88%) did not receive intraoperative supplemental intravenous 
fluids. Only 7 (12%) patients received greater than 15mL/kg of intravenous fluid during the 
intraoperative period.  
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Supplemental Intraoperative Intravenous Fluid Administration among Patients Undergoing 
Surgical Procedures and General Anesthesia for the Prevention of Postoperative 
Nausea and Vomiting: A Retrospective Chart Review 
Postoperative nausea and vomiting (PONV) is a common patient complication following 
surgery and anesthesia (Cao, White, & Ma, 2017). Postoperative nausea and vomiting can lead to 
patient dissatisfaction, prolonged hospital stays, increased costs and further medical 
complications (Cao et al., 2017).  Regardless of medical and surgical advances, PONV continues 
to affect 20-40% of surgical patients (Cao et al., 2017). 
Background  
Nausea can be defined as the feeling of needing to vomit while vomiting is defined as the 
instinctive reflex that involves the ejection of gastric contents (Squire & Spencer, 2018). 
Physiologically, the occurrence of PONV is complicated and involves both central and peripheral 
receptor mechanisms of the nervous system (Cao et al., 2017). The vomiting center in the brain is 
in the lateral reticular formation of the medulla (Jewer et al., 2019). The medulla coordinates 
efferent transmission to the respiratory, gastrointestinal, and abdominal musculature to generate 
vomiting (Jewer et al., 2019). The vomiting center receives afferent information from the 
pharynx, gastrointestinal tract stretch receptors, brain, aortic baroreceptors and chemoreceptor 
trigger zone (Jewer et al., 2019).  Commonly, patients present for surgery with decreased 
intravascular volume due to preoperative fasting. Intravascular dehydration can lead to a 
decrease in gastrointestinal perfusion which can contribute to PONV (Jewer et al., 2019). 
SUPPLEMENTAL INTRAOPERATIVE INTRAVENOUS                                                        8
Postoperative nausea and vomiting is an ongoing complication that negatively impacts 
patients following surgical procedures. Management of this common complication involves risk 
stratification, intraoperative treatment, and modification of anesthetic technique (Squire & 
Spencer, 2018). Postoperative nausea and vomiting can be distressing to patients and increases 
healthcare costs (Squire & Spencer, 2018). Risk factors that can lead to PONV are often grouped 
into patient, surgical and anesthetic factors (Squire & Spencer, 2018). Common patient risk 
factors for PONV include female gender, non-smoker, history of PONV, history of motion 
sickness, dehydration, and gastric distension (Squire & Spencer, 2018). Surgeries that commonly 
contribute to PONV risk are gynecological surgery, ears, nose and throat surgery, strabismus 
procedures, intra-abdominal surgeries, and neurosurgery (Squire & Spencer, 2018). General 
anesthesia, volatile anesthetics, nitrous oxide, intraoperative opioids, neostigmine, and 
intraoperative hypotension are anesthetic factors that all increase the risk of PONV (Squire & 
Spencer, 2018). Majority of these risk factors cannot be modified; therefore, it is important for 
anesthesia providers to deliver appropriate treatment during the intraoperative period to decrease 
the incidence of PONV.  
During the intraoperative period, adult patients receive intravenous fluids. However, 
anesthesia providers do not consistently administer intravenous fluids in a systematic manner 
during the surgical procedure. Antiemetic medications are commonly given for the prevention of 
PONV, but supplemental intravenous fluid administration is not consistently utilized for the 
prevention of PONV. The American Society of PeriAnesthesia Nurses (ASPAN, [2006]) 
recommends the administration of supplemental intravenous fluids for the prevention of PONV 
in high-risk patients with an American Society of Anesthesiologists (ASA) physical status of I or 
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II, with insensible losses when there is no concern of fluid volume overload. This is a Class IIa, 
Level A recommendation from ASPAN’s clinical practice guideline for the prevention and 
management of PONV (ASPAN, 2006). 
Problem Statement  
The use of supplemental intravenous fluids during the intraoperative period is not 
consistently utilized in the clinical setting. Since PONV is one of the most common patient 
complications following general anesthesia, a multimodal approach should be considered to 
successfully prevent this adverse effect. Intraoperative intravenous fluids are given to every adult 
patient during general anesthesia. However, the amount of fluids a patient receives is determined 
by the anesthesia provider. Dehydration alone is a risk factor for PONV, and current literature 
indicates supplemental fluid administration during the intraoperative period can aid in preventing 
PONV (Squire & Spencer, 2018). This DNP projects aims to identify the overall occurrence of 
PONV at the project site and if anesthesia providers are currently using supplemental fluid 
administration practices for the prevention of PONV. The clinical question remains, are adult 
patients undergoing surgical procedures with general anesthesia who experienced PONV, 
receiving supplemental intravenous fluid practices during the intraoperative period for the 
prevention of PONV?  
Organizational “Gap” Analysis of Project Site 
The project site for this DNP project does not currently utilize supplemental fluid 
administration practices for the prevention of PONV, nor is a protocol in place recommending 
this practice. After observation, the organization appears to be consistent with administering 
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medications for the prevention of PONV, both preoperatively and intraoperatively. However, 
based on personal observations within the site, fluid administration practices are commonly 
restrictive at this facility and not often considered for the prevention of PONV. When discussing 
with anesthesia providers at this facility, the majority describe a culture in the organization that 
supports restrictive fluid administration practices intraoperatively. Although, opinions differ 
among anesthesia providers at the project site.  
Review of the Literature 
 A review of current literature was conducted in September 2019. Search terms utilized in 
the search included supplemental intraoperative intravenous fluids and postoperative nausea and 
vomiting. Databases used for the literature search included Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), PubMed, the Cochrane Library, and Google Scholar. 
Inclusion criteria for articles within the literature review were systematic reviews, meta-analyses 
or randomized control trials that involved the comparison of supplemental intravenous fluids, 
standard or restrictive fluid administration practices during the intraoperative period among adult 
patients undergoing general anesthesia. The articles must have been published after 2009. A 
limited number of articles were identified that met inclusion criteria. When searching via 
PubMed database a total of 36 articles were yielded. Six articles were included in the literature 
review, two of the articles were systematic reviews and the remainder randomized control trials. 
Articles excluded were those studying children and those with no comparison of supplemental 
fluid administration with restrictive or standard fluid practices. 
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 Postoperative nausea and vomiting continues to be a major complication following 
general anesthesia. The incidence of PONV can be as high as 80% among patients who are 
considered high risk (Apfel et al, 2012). The occurrence of PONV not only negatively impacts 
patients, but also increases healthcare costs by delaying discharge and causing readmission to the 
hospital (Apfel et al., 2012). There are several antiemetic medications available for the 
prevention of PONV. However, the use of these medications can be costly and cause unwanted 
side effects (Apfel et al., 2012). It is believed that dehydration is a major contributor to PONV. 
Supplemental intravenous fluid administration may be an inexpensive solution to prevent PONV 
and limit medication use that leads to unwanted side effects. However, fluid administration 
practices differ greatly among anesthesia providers. In addition, there are several factors that 
must be considered when choosing how much intravenous fluids a patient receives during the 
intraoperative period, including type of surgical procedure and patient medical history.  
Within the literature the definition of supplemental fluid administration differs. 
Supplemental intravenous fluid administration practices among studies within the literature 
review for the prevention of PONV ranged between 10mL/kg and 30mL/kg during the 
preoperative or intraoperative period. One study compared the administration of 10mL/kg with 
30mL/kg of intravenous fluids during the intraoperative period among patients receiving 
diagnostic laparoscopic gynecological surgery (Chauhan et al., 2013). This study found that 66% 
of patients who received 10mL/kg of intravenous fluid experienced PONV in the first four hours 
after surgery, while only 40% of the patients in the group who received 30mL/kg of intravenous 
fluids experienced PONV (Chauhan et al., 2013). A second study compared the effects of 30mL/
kg of intravenous fluids plus 5mg of dexamethasone with the administration of 5mg of 
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dexamethasone alone for female patients undergoing laparoscopic cholecystectomy (Ismail et al., 
2017). This study found the overall occurrence of PONV during the first 24 hours 
postoperatively was significantly reduced (22%) among the group of patients who received the 
30mL/kg of intravenous fluids plus dexamethasone than the comparison group (44%) who 
received dexamethasone only (Ismail et al., 2017). Another randomized double-blind study 
included and compared three separate patient groups. One patient group received 10mL/kg of 
lactated ringers, the second group received 20mL/kg and the third group 30mL/kg (Sharma et al., 
2010). This study discovered the mean score of the visual analogue scale (VAS) for nausea and 
vomiting was significantly higher in patients who only received 10mL/kg of lactated ringers 
when compared to  the groups of patients who received 20mL/kg or 30mL/kg of lactated ringers 
(Sharma et al., 2010). The final study also compared three different patient groups, one group 
received routine hydration alone, defined as 1.5mL/kg/h of normal saline, the second group 
received routine hydration plus 5mL/kg of lactated ringers 80 to 90 minutes prior to surgery and 
the third group received routine hydration plus 5mL/kg intraoperatively (Soleimani et al., 2018). 
Soleimani et al. (2018) found patients who received additional intravenous fluids preoperatively 
had significantly lower PONV when compared to the patient groups who received routine 
hydration and those who received routine hydration plus additional fluids intraoperatively 
(Soleimani et al., 2018). In addition, this study found patients who received additional 
intraoperative fluids had an overall decrease number of incidences of PONV when compared to 
the group of patients who received routine hydration only (Soleimani et al., 2018). Two 
systematic reviews were also discovered while reviewing the literature. Both systematic reviews 
included studies that examined the administration of supplemental intravenous fluid 
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administration greater than that received from the comparison group (Apfel et al., 2012, Jewer et 
al., 2019). One systematic review included 15 studies and found supplemental fluid 
administration significantly reduces the overall incidence of PONV (Apfel et al., 2012). The 
systematic review completed by Jewer et al. (2019) included 41 studies and found with moderate 
certainty, supplemental intraoperative intravenous fluids reduces the incidence PONV during the 
overall postoperative period. Regardless of the differing volumes received, all studies within the 
literature review found the use of supplemental fluid administration practices reduced the overall 
incidence of PONV when compared to patients who received lesser volumes of intravenous fluid 
(Apfel, 2012; Chauhan et al., 2013; Ismail, Bakri, & Abd-Elshafy, 2017, Jewer et al, 2019, 
Sharma, 2010, Soleimani et al., 2018). In addition, the review of literature also revealed patients 
who received supplemental fluid administration had an overall reduction in the use of 
antiemetics during the postoperative period (Apfel, 2012; Chauhan et al., 2013; Ismail, Bakri, & 
Abd-Elshafy, 2017, Jewer et al, 2019, Sharma, 2010, Soleimani et al., 2018). See Appendix A for 
literature matrix.  
Several studies identified within the literature review examined the occurrence of PONV 
over an extended period of time and examined postoperative nausea and postoperative vomiting 
separately. Apfel et al. (2012) and Jewer et al. (2019) both reported a reduction in postoperative 
nausea during the early postoperative period in patients who received supplemental intravenous 
fluid. Apfel et al. (2012) found no reduction in early or late postoperative vomiting, but Jewer et 
al. (2019) reported a decrease in early and late postoperative vomiting in patients who received 
supplemental intravenous fluids. Ismail et al. (2017) did not find any significant difference in 
early or late PONV among patients who received supplemental intravenous fluid. While some of 
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the studies differ slightly in their results, all studies within the literature review found an overall 
reduction in PONV among patients who received supplemental intravenous fluids (Apfel, 2012; 
Chauhan et al., 2013; Ismail, Bakri, & Abd-Elshafy, 2017, Jewer et al, 2019, Sharma, 2010, 
Soleimani et al., 2018).  
Two studies within the literature review also examined the effects of postoperative pain 
following the administration of supplemental fluid administration. Both studies found a 
significant reduction of pain scores in patients who were treated with supplemental fluid 
compared to those who received a lower volume of intravenous fluids during the intraoperative 
period (Ismail, Bakri, & Abd-Elshafy, 2017, Soleimani et al., 2018). Soleimani et al. (2018) 
found that pain scores were significantly lower among patients who received supplemental fluid 
during the preoperative period. Ismail, Bakri and Abd-Elshafy, (2017) found the mean VAS pain 
score during the first 24 hours postoperatively was lower among patients who received 
supplemental fluid administration compared to those who did not.  
Current literature suggests there are advantages to the use of supplemental fluid 
administration practices during the intraoperative period among ASA physical status I and II 
patients undergoing general anesthesia for the prevention of PONV. However, after completing 
the literature review there are some limitations. Majority of the studies only included women and 
ASA physical status I or II patients. In addition, the definition of supplemental intravenous fluids 
differed among the studies and is not clearly defined at the conclusion of the review. Very few 
studies mentioned adverse events related to supplemental fluid administration practices.  
Additional studies are needed to examine potential adverse side effects of supplemental fluid 
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administration practices and to establish a clear definition of how much fluid is necessary to 
prevent PONV.  
Evidence Based Practice: Verification of Chosen Option 
According to the clinical practice guideline created by the American Society of 
PeriAnesthesia Nurses (ASPAN), adequate hydration is one intervention that can be used for the 
prevention and treatment of PONV (ASPAN, 2006). Specifically, ASPAN recommends patients 
who are at risk for PONV who have an ASA physical status I or II should receive supplemental 
intravenous fluids (ASPAN, 2006). The clinical practice guideline recommends the use of 15 to 
40mL/kg of lactated ringers to patients who are not at risk for fluid volume overload (ASPAN, 
2006).  
After a review of current literature related to supplemental intraoperative intravenous 
fluid administration, several studies have found supplemental intravenous fluid administration of 
20 to 30mL/kg during the intraoperative period can lower the incidence of PONV (Apfel, 2012; 
Chauhan et al., 2013; Ismail, Bakri, & Abd-Elshafy, 2017, Jewer et al, 2019, Sharma, 2010, 
Soleimani et al., 2018). This DNP project will evaluate the overall occurrence of PONV at the 
project site and if anesthesia providers are utilizing this current recommendation within their 
practice at the project site.  
Theoretical (Conceptual) Framework 
The purpose of the project is to identify the overall PONV occurrence and if patients who 
experienced PONV received supplemental intravenous fluids during the intraoperative period for 
the prevention of PONV. This project will examine and identify if anesthesia providers are 
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utilizing fluid management practices for the prevention of PONV to improve patient outcomes. 
Adult patients undergoing surgical procedures and general anesthesia receive intravascular fluids 
during the intraoperative period. The amount of intravascular fluids a patient receives is 
determined by the actions and decisions of the anesthesia provider. Reflecting upon current and 
previous fluid administration practices can aid in improving patient outcomes and reducing 
PONV in patients undergoing surgical procedures. Utilizing the Theory of Reflective Practice in 
Nursing can help guide the practice of nurses and advanced practice nurses to lead a fully 
reflective clinical nursing practice. 
Reflection in nursing practice is considered a vital component to providing high quality 
patient care. Originally, reflective practice was discussed by Schon within both nursing practice 
and nursing education (Choperena, Oroviogoicoechea, Salcedo, Moreno, & Jones, 2019). 
Reflective practice suggests professional practice involves an evolving process of utilizing 
knowledge, experience, and intuition in the clinical setting (Choperena et al., 2019).  The Theory 
of Reflective Practice in Nursing is a middle range nursing theory (Galutira, 2018). This theory 
suggests nurses need to reflect upon their nursing practice including reflection-before-action, 
reflection-in-action, and reflection-beyond-action (Galutira, 2018). Nurses who practice 
reflection when providing care can improve quality of care, impact professional development, 
and improve care outcomes (Galutira, 2018).  
 There are five key concepts within The Theory of Reflective Practice in Nursing: 
reflection, clinical situation or experience, promoting factors, hindering factors, and outcomes 
(Galutira, 2018). A diagram reflecting the relationship of the five key concepts can be found in 
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Appendix B. Reflection is an active evolving process that consists of exploration of personal 
feelings, thoughts, and actions (Galutira, 2018). Reflection-before-action consists of reflecting 
before emerging into a clinical practice situation (Galutira, 2018). Reflection-in-action entails 
reflective thinking during the clinical situation, and involves the immediate decision making of 
nurses while at the bedside (Galutira, 2018). Reflection-beyond-action is the critical analysis that 
occurs after the clinical situation (Galutira, 2018). Reflection-beyond-action also occurs after the 
clinical situation but involves utilizing a nurse’s experience in clinical practice to improve upon 
professional practice (Galutira, 2018). The clinical situation or experience is described as an 
event that involves the patient, family, group or community and the nurse, that requires a solution 
to a clinical practice problem (Galutira, 2018).  Promoting factors are factors that support the 
nurse in leading a reflective practice (Galutira, 2018). For example, these factors can include 
supportive workplace culture, positive attitudes, adequate time, and developed cognitive skills 
(Galutira, 2018). Hindering factors are the opposite of promoting factors and cause a hinderance 
to a nurse’s ability to reflect in practice (Galutira, 2018). Lastly, outcomes are the positive results 
that occur due to reflection (Galutira, 2018). These results can include improved patient care 
outcomes, improved quality of nursing care, personal development, and professional growth 
(Galutira, 2018). There are many patient factors that can be considered when determining fluid 
management in a patient undergoing general anesthesia and a surgical procedure. A retrospective 
chart review is one example of how one may reflect-beyond-action. This involves reviewing and 
collecting data to aid in discovering a problem within clinical practice. Applying The Theory of 
Reflective Practice in Nursing within this aspect of anesthesia care can encourage certified 
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registered nurse anesthetists (CRNAs) to utilize reflection to improve upon all aspects of patient 
care.  
Goals, Objectives, and Expected Outcomes  
The main objective of the project is to discover the overall occurrence of PONV at the 
project site and if supplemental fluid administration practices of greater than 15mL/kg are being 
utilized within the clinical setting for the prevention of PONV. My goals for the project are listed 
below.  
1. Discover current recommendations and literature for fluid management practices 
related to the prevention of PONV by November 2019.  
2. Identify the overall occurrence and number of patients who experienced and were 
treated for PONV at the project site during a one-month timeframe by March of 2020.  
3. Identify the percentage of patients who experienced PONV that did not receive 
supplemental fluid administration during the intraoperative period during the month 
of March 2020.  
4. Identify areas for quality improvement or protocol development within the project 
site at the completion of the project in August 2020.  
The purpose is to identify care patterns among anesthesia providers and gaps in practice, which 
will ultimately lead to recommendations for future improvement for the management and 
prevention of PONV. It is expected to find that most patients at the project site who underwent 
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general anesthesia and experienced PONV during the month of January 2020 did not receive 
supplemental intravenous fluid greater than 15mL/kg during the intraoperative period. 
Project Design  
This DNP quality improvement project will utilize a retrospective chart audit using 
previously recorded data. The project will utilize a quantitative descriptive approach to obtain 
data to evaluate if supplemental fluid administration practices are currently being utilized in 
clinical practice at the project site for the prevention of PONV. The project will be a retrospective 
convenience sample of adult patients who underwent a surgical procedure during the month of 
January 2020. The goal of the project is to reach a sample size of 50 patients. Upon the review of 
patient charts, the marker for further inclusion into the project is patients medicinally treated for 
PONV during phase one or phase two of the postoperative period who received general 
anesthesia. The EHRs of patients who received general anesthesia during this timeframe and 
were medicinally treated for PONV will be further reviewed to assess the intraoperative 
anesthesia record. Additional data collected will include ASA physical status, age, gender, 
amount of intravenous fluids received during the intraoperative period, weight, and surgical 
procedure. After data collection, data analysis will be performed to identify if patients who 
experienced PONV received the recommended fluid administration for the prevention of PONV. 
The data collected will provide insight on current fluid administration practices at the clinical site 
and the overall occurrence of PONV.  
Project Site and Population 
SUPPLEMENTAL INTRAOPERATIVE INTRAVENOUS                                                        20
The DNP project will be implemented at a Midwestern hospital. This facility is a private, 
non-profit, Level III Trauma Center with 191-beds and Magnet Designation located in the 
Midwest (Indiana University Health, 2019). The county in which this facility is located is a 
predominately white community that has a population of 195,732 (Unites States Census Bureau, 
n.d.) See Strengths Weakness Opportunities (SWOT) Analysis Appendix F. 
The patient population that will be included in the retrospective chart review are adult 
patients 18 years of age and older who underwent a surgical procedure and general anesthesia 
during the selected timeframe. Excluded were children 17 years of age and younger and patients 
who received other primary anesthesia techniques not considered general anesthesia as 
documented in the intraoperative anesthesia record, such as monitored anesthesia care (MAC) or 
a regional anesthetic.  
Setting Facilitators and Barriers  
This project site is affiliated with an academic institution and has current evidence-based 
protocols in place. This may facilitate the DNP project and professionals may be more accepting 
of recommendations following the completion of the project. However, the anesthesia 
department at the project site is staffed by both physician anesthesiologists and CRNAs. The two 
varying anesthesia backgrounds within the project site may be a barrier to producing practice 
changes at the facility.   
Methods 
The project is intended to identify a gap in clinical practice and evidence-based 
guidelines related to supplemental intravenous fluids for the prevention of PONV. The project 
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will be completed by utilizing a retrospective chart review. A project site has been selected and a 
project mentor has agreed to provide access to EHRs to complete the chart audit. Since data 
collected is from human subjects, an application for exemption from Marian University’s 
Institutional Review Board (IRB) will be completed before data collection begins. Once an 
exemption is granted from the IRB, the retrospective chart review may begin. No informed 
consent is needed, as only previously recorded data will be reviewed. A systematic process has 
been created to collect data once individual patient charts are accessed. Patients older than 18 
years of age who underwent surgical procedures during the selected timeframe will be included 
in the review. Once patients who were treated for PONV and received general anesthesia are 
identified during the selected timeframe, data related to the amount of intravenous fluids 
received during the intraoperative period, ASA physical status, age, gender, and surgical 
procedure will also be collected. This data will be analyzed to determine the number of patients 
who experienced PONV and received ASPAN’s recommended amount of intraoperative fluids of 
at least 15mL/kg for the prevention and management of PONV. Once data is analyzed 
recommendations will be made regarding supplemental fluid administration practices for the 
prevention of PONV.  
Measurement Instrument 
All information collected for this DNP project will be obtained from patient EHRs. Data 
collected will be placed into a Microsoft Excel spreadsheet. Data analysis will also be completed 
using Microsoft Excel. The weight of the patient and the amount of intravenous fluids received 
during the intraoperative period will be recorded to calculate milliliters per kilogram of 
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intravenous fluids each patient received.  Additional variables will be collected during the 
retrospective chart review to allow for a better understanding of the patient population 
experiencing PONV. The gender of each patient included in the study will be identified to 
determine if one gender is more impacted from PONV. The age of each patient will also be 
recorded to better describe the population within the project. The ASA physical status will be 
collected to further provide information on the patient population and help identify patients who 
may qualify for supplemental fluid administration practices. The type of surgical procedures 
patients underwent will also be collected to identify if certain surgical procedures were 
commonly recorded among the patients who experienced PONV. All these data points will be 
obtained from the medication administration record (MAR) and the anesthesia record located in 
patient EHRs. 
The weight of each patient who had experienced PONV will be obtained from the 
anesthesia record within the EHR. Since the project is a retrospective chart review the reliability 
and validity of the measurement devices are not able to be determined. The measurement of 
PONV during the postoperative period will be determined by patient medicinal treatment for 
nausea or vomiting during phase one or phase two of the postoperative period. After speaking 
with post-anesthesia care unit (PACU) registered nurses at the project site, many stated they do 
not consistently chart the occurrence of nausea or vomiting within the patient’s physical 
assessment. The nurses stated they will treat a patient for PONV with medications ordered for 
the postoperative period by the anesthesia provider. Therefore, assessing the administration of 
medications for the treatment of PONV will be a more accurate evaluation for occurrence of 
PONV.  
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There are several medicinal options that an anesthesia provider may order for the 
treatment of PONV. At the project site, the medications ordered for PONV are specified to be 
given as needed for nausea or vomiting only. The medication administration record (MAR) of 
each patient will be examined to identify if the patient was given medication ordered by the 
anesthesia provider to treat PONV. The accuracy of the collected data is dependent on the quality 
of the data originally entered into the chart.  
Data Collection Procedures 
Data for this project will be manually and systematically collected via a retrospective 
patient chart review utilizing EHRs. The project mentor will aid in giving access to patient EHRs 
for the collection of data. Patient charts will be reviewed for the entire month of January 2020. 
Patients charts who are over the age of 18 who underwent a surgical procedure during January 
2020 will be included in the review.  
The chart review was completed in March of 2020. Data collected was entered into a 
Microsoft Excel spreadsheet throughout the data collection process. Data collected via Microsoft 
Excel file contained no identifying patient health information. The data collection file was saved 
within the password protected secure One Drive-Marian University cloud.  
The surgical schedule from January 1, 2020 to January 31, 2020 at the project site was 
identified. The EHRs of adult patients who underwent a surgical procedure that required general 
anesthesia during this timeframe were accessed. Upon access to individual patient EHRs, the 
anesthesia record was reviewed to determine if the patient underwent a general anesthetic. Next, 
the patient’s MAR was evaluated to determine if the patient was medicinally treated for PONV 
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during phase one or phase two of the postoperative period. If the patient received general 
anesthesia and was treated for PONV, additional data was collected from the anesthesia record 
including age, gender, weight, surgical procedure, ASA physical status, and amount of 
intraoperative intravenous fluids received. The EHRs of patients who were under the age of 18, 
underwent a surgical procedure where they would not be receiving care in the PACU, or 
underwent a procedure that did not require general anesthesia were not accessed.  
Data Analysis  
The aim of the project is to identify the overall occurrence of PONV, and the amount of 
intraoperative intravenous fluids patients received who were treated for PONV. Data analysis via 
Microsoft Excel will include descriptive statistics. Nominal variables will be measured via count, 
such as gender and ASA physical status. Continuous variables of mean, median and range, will 
be calculated for age and amount of intravenous fluids received in milliliters per kilogram via 
Microsoft Excel. The amount of intravenous fluids received in milliliters will be divided by the 
weight of the patient in kilograms to determine how many milliliters per kilogram each patient 
received during the intraoperative period. Once milliliters per kilogram of intravenous fluids 
received among patients who experienced PONV is determined, data analysis will be completed 
to determine the number of patients that received greater than or less than 15mL/kg.  This data 
will then be compared to current guidelines and recommendations in literature to detect areas for 
quality improvement for the prevention of PONV at the project site.  
Results 
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 During the month of January 2020, 342 patient EMRs were reviewed to determine if 
adult patients who received general anesthesia were treated for PONV during the postoperative 
period. Of those 342 patients, 57 (17%) patients were identified to be treated for PONV during 
phase one or phase two of the postoperative period and included for further data collection. 
Forty-four of the patients were female and the remaining 13 were male. Two patients were given 
ASA physical status of I, 26 patients were considered ASA physical status II, 28 were ASA 
physical status III and one patient was classified as ASA physical status IV. The mean age of the 
included patients was 50 years old, median age 48, lowest age 19 and highest age 86 (See graphs 
and tables of demographic data Appendix D). The mean amount of intravenous fluids received 
was 10mL/kg the median was 9.2mL/kg, the minimum was 3mL/kg, the maximum was 34.8 mL/
kg and the standard deviation was 6.1mL/kg.  Fifty (88%) patients out of the 57, received less 
than 15mL/kg of intravenous fluid during the intraoperative period, four (7%) patients received 
between 15 and 20mL/kg of intravenous fluid, one (2%) patient received between 20.1 and 
30mL/kg and two (3%) patients received greater than 30mL/kg of intravenous fluid. Of the 57 
patients included in the review, 28 were classified as ASA physical status I or II. When only 
considering ASA physical status I or II patients in the project, 24 (86%) did not receive greater 
than 15mL/kg of intravenous fluid during the intraoperative period while the remaining four 
(14%) patients received greater than 15mL/kg of intravenous fluid (See graphs representing data 
Appendix E). Twenty-eight (48%) of the surgical procedures were intra-abdominal with 22 of 
these utilizing a laparoscopic technique.  
Interpretation/Discussion 
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 The results from the DNP project discovered that supplemental fluid administration 
practices are not being utilized for the prevention of PONV at the project site. According the 
clinical practice guideline created by ASPAN, administration of supplemental intravenous fluids 
in ASA I or II patients if there is no risk for fluid volume overload should be considered for the 
prevention of PONV (ASPAN, 2006). This guideline explains that the administration of 15 to 
40mL/kg of lactated ringers has been shown to decrease PONV in this patient population 
(ASPAN, 2006). Of all the patients who experienced PONV included in the project, 88% 
received less than the recommended intravenous fluids of 15mL/kg, only 7% of the patients 
received between 15 and 20mL/kg, 2% received between 20.1 and 30mL/kg and 3% received 
greater than 30mL/kg. When only considering ASA physical status I and II patients, 86% 
received less than 15mL/kg of intravenous fluids during the intraoperative period. This data 
suggests that there is room for improvement for prevention PONV at this project site utilizing 
supplemental fluid administration practices.  
Cost-Benefit Analysis/Budget 
 There was no cost for the implementation of this DNP project to the organization where it 
was performed. The DNP student utilized practicum hours to complete the implementation and 
evaluation of the project. If the project were to be implemented at the project site facility the cost 
would be the salary of the individual completing the retrospective chart review.  
Timeline  
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The proposed project is expected to take a total of one year to complete. The project first 
began in August 2019 and the goal is to complete the project by August 2020 (See GANTT chart 
Appendix C). 
Ethical Considerations/Protection of Human Subjects 
 The overall objective of this project was to implement an evaluation to determine if 
practice changes are needed to improve patient quality of care and outcomes. Before beginning 
the implementation phase of the project, the Institutional Review Board at Marian University 
granted an exemption on February 2020 for this DNP project. Throughout the duration of the 
project, no patient identifying health information was collected and the Health Insurance 
Portability and Accountability Act (HIPAA) standards were maintained. Also, this DNP project 
upheld the Marian University values throughout its duration. Specifically, the Marian University 
value dignity of the individual was upheld by keeping patient information private and respecting 
each human that was included in the project.  
Conclusion 
 Postoperative nausea and vomiting is an unpleasant complication that can occur after 
receiving general anesthesia.  This common complication can negatively impact both patient 
satisfaction and healthcare costs (Cao et al., 2017). Supplemental intravenous fluid 
administration during the intraoperative period is currently recommended by ASPAN for the 
prevention of PONV (ASPAN, 2006). However, it appears supplemental fluid administration 
practices are not consistently used in the practice setting.   
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This DNP project involved a retrospective chart review to determine the overall incidence 
of PONV and to evaluate if current anesthesia practices related to supplemental fluid 
administration for the prevention of PONV is currently being utilized within the project site. The 
retrospective chart review found a total of 57 patients were treated for PONV during phase one 
or phase two of the postoperative period during the month of January 2020. Of the 57 patients 
who experienced PONV, only seven patients received greater than 15mL/kg of intravenous fluid 
during the intraoperative period, four patients received between 15 and 20mL/kg and of 
intravenous fluid, one patient received between 20.1 and 30 mL/kg of intravenous fluid and two 
patients received greater than 30mL/kg. Of the 57 patients who experience PONV, 28 of the 
patients were ASA physical status I or II. Of those 28 patients, only 4 patients received greater 
than 15mL/kg during the intraoperative period. Current recommendations from the clinical 
practice guideline written by ASPAN (2006) states that patients who are at high risk for PONV, 
who have an ASA physical status of I or II and are not at risk for fluid volume overload should 
receive supplemental fluid administration of 15 to 40mL/kg for the prevention of PONV. In 
addition, the review of literature also identified supportive current research related to the use of 
supplemental fluid administration for the prevention of PONV. Following the data analysis, this 
project site could benefit from utilizing supplemental intravenous fluid administration practices 
for the prevention of PONV for patients undergoing general anesthesia.  
While not all patients are candidates for supplemental fluid administration practices, it 
appears this project site has the population in which this practice could be utilized. Nearly half of 
the patients who experienced PONV during the month of January 2020 were ASA physical status 
I or II. Protocols or recommendations for the consideration of utilizing supplemental fluid 
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administration practices for the prevention of PONV for specific surgical procedures and patient 
populations may be beneficial to both patients and the project site.  
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Appendix B 
 
Figure 1. The Theory of Reflective Practice in Nursing Conceptual Framework (Galutira, 2018) 
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Appendix C 
GANTT Chart 





Graph 1. Distribution of ASA physical status 
 
Graph 2. Distribution of gender 
 
Table 1. Distribution of age 
N Mean Median Minimum Maximum
Age 57 50 48 19 86




Graph 3. Intraoperative Intravenous Fluids Received mL/kg 
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Graph 4. Intraoperative Intravenous Fluids Received mL/kg ASA I and II Patients Only 
 
Graph 5. Number of patients that received greater than 15mL/kg 
Graph 6. Number of patients that received greater than 20mL/kg 







SUPPLEMENTAL INTRAOPERATIVE INTRAVENOUS                                                        46
Graph 7. Number of patients that received greater than 30mL/kg  
 
Table 2. Distribution of intravenous fluids mL/kg 
Mean Median Minimum Maximum SD
mL/kg of fluids received 10 9.2 3 34.8 6.1
SUPPLEMENTAL INTRAOPERATIVE INTRAVENOUS                                                        47
Appendix F 
  SWOT Analysis 
















• Academic Institution 
• Magnet Designated Facility 
• Evidence Based Protocols 
currently in place 
• Supportive Environment 
(Indiana University Health, 2019) 
Weaknesses 
• No current standards involving 
fluid administration in place for 
the prevention of PONV 
 
Opportunities 
• Improve patient outcomes 
• Reduce costs 
• Improve patient satisfaction 
• Develop protocol regarding 
fluid management for the 
prevention of PONV 
• Improve provider knowledge 
• Identify practice improvement 
Threats 
• Inability to reach consensus 
between differing anesthesia 
providers (MDA vs CRNA) 
• Restrictive fluid therapy 
practices 
• Fear of adverse effects related 
to supplement fluid practices 
